Data - AI
Use case n°1: treatment adherence enhancement through treatment reminders and medication management In the complex world of healthcare, adhering to treatment plans and medication schedules is ...
Healthcare
Rare disease drug development challenges Challenge n°1: small patient populations exacerbate clinical trials Finding a sufficient number of patients who meet the inclusion and exclusion criteria ...
Healthcare
Continuous monitoring allows early detection Traditionally, clinical medicine relies upon “snapshot” measurements captured at singular or limited timepoints, assisting in determining a final ...
Healthcare
Complications and management of sickle cell disease: a lifelong challenge What is sickle cell disease? Sickle cell disease is one of the most common hereditary diseases worldwide and the most ...
Healthcare
A not so “uncommon” rare disease Each year about 300,000 babies are born with sickle cell disease globally, with a vast majority in sub-Saharan Africa. Millions of people are suffering from the ...
Healthcare
Challenge n°1: Develop knowledge about rare diseases Research into rare diseases is hampered by a lack of knowledge of the biological mechanisms involved and a limited understanding of how these ...
Cross-sector
What are co-products? A co-product is an unavoidable byproduct of an industrial process which can be collected and then reused to generate new products. In 2018, the “Réseau pour la Sécurité et ...
Healthcare
What is the link between undernutrition and chronic diseases? Patients with chronic diseases, such as renal failure or cancer, are at an increased risk of undernutrition. However, the lack of ...
Agrifood
A dynamic market dominated by the USA Aimed at both amateur and professional athletes, sports nutrition encompasses a variety of products designed to support physical performance, muscle recovery ...
Cosmetics
Trend n°1: personalized beauty Personalized beauty is a trend making a strong come back with firstly the emergence of diagnostic tools to have adapted recommendations and then, the development of ...